PT  - JOURNAL ARTICLE
AU  - Alysa J. Martin
AU  - Stephanie Shulder
AU  - David Dobrzynski
AU  - Katelyn Quartuccio
AU  - Kelly E. Pillinger
TI  - Risk Factors Associated with Increased Antibiotic Use in COVID-19 Hospitalized Patients
AID  - 10.1101/2020.10.21.20217117
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.21.20217117
4099  - http://medrxiv.org/content/early/2020/10/25/2020.10.21.20217117.short
4100  - http://medrxiv.org/content/early/2020/10/25/2020.10.21.20217117.full
AB  - Literature suggests that antibiotic prescribing in COVID-19 patients is high, despite low rates of confirmed bacterial infection. There are little data on what drives prescribing habits. This retrospective, multi-center, observational study sought to determine antibiotic prescribing rates and risk factors for antibiotic prescribing in hospitalized patients. Patients admitted from March 1, 2020 to May 31, 2020 and treated for PCR-confirmed COVID-19 were included. The primary endpoint was the rate of antibiotic use during hospitalization. Secondary endpoints included risk factors associated with antibiotic use, risk factors associated with receiving more than one antibiotic course, and rate of microbiologically confirmed infections. A total of 208 encounters (198 patients) were included in the final analysis. Eighty-three percent of patients received at least one course of antibiotics, despite low rates of microbiologically confirmed infection (12%). Almost one-third of patients (30%) received more than one course of antibiotics. There was a low rate of respiratory cultures obtained (32%). Risk factors identified in a univariate analysis for both antibiotic prescribing and receiving more than one course of antibiotics were more serious illness, increased hospital length of stay, ICU admission, mechanical ventilation, and ARDS. This study highlights the need for increased antibiotic stewardship practices in COVID-19 patients. Further studies should be conducted to determine the utility of different stewardship initiatives in COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no funding for this projectAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was deemed exempt from review by the University of Rochester Medical Center Research and Subjects Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis research is based on data collected within our institution. No databases were used for the completion of this project.